Author:
Jiang Yong-fang,Ma Jing,He Yan,Zhang Yong-hong,Xu Yun,Gong Guo-zhong
Publisher
Zhejiang University Press
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Veterinary,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference35 articles.
1. Bereznaya, N.M., Chekhun, V.F., 2007. Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy. Exp. Oncol., 29(1):2–12.
2. Bullens, D.M., Kasran, A., Thielemans, K., Bakkus, M., Ceuppens, J.L., 2001. CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand. J. Immunol., 53(5):455–463. [doi:10.1046/j.1365-3083.2001.00900.x]
3. Buning, C., Kruger, K., Sieber, T., Schoeler, D., Schriever, F., 2002. Increased expression of CD40 ligand on activated T cells of patients with colon cancer. Clin. Cancer Res., 8(4):1147–1151.
4. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A., Blay, J.Y., 1997. The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today, 18(10):493–497. [doi:10.1016/S0167-5699(97)01115-8]
5. Diehl, L., Den Boer, A.T., Schoenberger, S.P., ven der Voort, E.I., Schumacher, T.N., Melief, C.J., Offringa, R., Toes, R.E., 1999. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat. Med., 5(7):774–779. [doi:10.1038/10495]
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献